当前位置:首页 - 行情中心 - 康弘药业(002773) - 财务分析

康弘药业

(002773)

  

流通市值:285.03亿  总市值:382.34亿
流通股本:6.87亿   总股本:9.21亿

康弘药业(002773)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润7.22亿元,每股收益0.79元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益884906.82万元,未分配利润539985.42万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产953273.70万元,负债68366.89万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入2,453,661,937.961,198,743,422.584,452,657,7993,411,293,193.61
营业总成本1,619,188,513.48749,205,765.443,160,129,826.792,311,766,338.66
其他经营收益
营业利润864,603,231.25465,577,222.61,381,329,866.491,148,722,614.3
利润总额852,462,294.74462,805,135.381,352,536,967.131,138,170,500.15
净利润721,864,033.83396,624,766.471,177,008,069.02964,889,830.03
每股收益
其他综合收益-64,852.09-518,692.2713,717.61-148,087.22
综合收益总额721,799,181.74396,106,074.21,177,021,786.63964,741,742.81
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计6,632,270,664.096,698,071,185.536,288,819,404.186,203,269,721.25
非流动资产:
非流动资产合计2,900,466,376.232,974,666,719.183,053,116,935.493,009,559,372.19
资产总计9,532,737,040.329,672,737,904.719,341,936,339.679,212,829,093.44
流动负债:
流动负债合计646,420,489.64585,887,181.92654,992,016.68735,492,143.57
非流动负债:
非流动负债合计37,248,375.3341,637,083.0340,077,243.0942,756,564.49
负债合计683,668,864.97627,524,264.95695,069,259.77778,248,708.06
所有者权益(或股东权益):
归属于母公司股东权益合计8,862,968,325.249,054,671,602.238,653,202,130.158,435,514,491.73
股东权益合计8,849,068,175.359,045,213,639.768,646,867,079.98,434,580,385.38
负债和股东权益合计9,532,737,040.329,672,737,904.719,341,936,339.679,212,829,093.44
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计2,648,154,933.641,241,777,235.334,848,082,350.553,684,526,280.03
经营活动现金流出小计1,732,368,612.54808,699,338.893,436,207,512.822,430,058,668.41
经营活动产生的现金流量净额915,786,321.1433,077,896.441,411,874,837.731,254,467,611.62
投资活动产生的现金流量:
投资活动现金流入小计2,649,006,743.42348,814.364,380,064,069.692,132,043,970.54
投资活动现金流出小计5,379,725,030.492,687,500,476.514,492,120,322.054,448,980,731.72
投资活动产生的现金流量净额-2,730,718,287.07-2,687,151,662.15-112,056,252.36-2,316,936,761.18
筹资活动产生的现金流量:
筹资活动现金流入小计29,342,742.5270,0006,748,052.16,747,149.4
筹资活动现金流出小计554,290,982.551,476,919.36350,887,348.05349,945,523.88
筹资活动产生的现金流量净额-524,948,240.05-1,206,919.36-344,139,295.95-343,198,374.48
汇率变动对现金及现金等价物的影响-2,359.72-366,606.53-246,263.46-746,257.11
现金及现金等价物净增加额-2,339,882,565.74-2,255,647,291.6955,433,025.96-1,406,413,781.15
期末现金及现金等价物余额3,285,544,680.823,369,779,954.965,625,427,246.563,263,580,439.45
补充资料:
现金及现金等价物的净增加额-2,339,882,565.74-955,433,025.96-
最新报告期:2025-07-23
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中泰证券曹泽运,祝嘉琦,穆奕杉1.481.641.772025-07-23
TOP↑